搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
7 天
on MSN
Ru5 identified as potent antitumor agent targeting mitochondrial ATPase
A research team identified Ru5 as a potent antitumor agent by screening a panel of ruthenium(II) polypyridine complexes ...
1 小时
Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in ...
Phase 1 study showed significant lung uptake and enhanced epithelial lining fluid (ELF) and alveolar macrophage (AM) ...
BioWorld
1 天
Dantrolene shows benefits in treating Darier disease pathology
Darier disease (DD) is a rare cutaneous disease caused by heterozygous mutations in the ATP2A2 gene, which encodes sarco/endoplasmic reticulum calcium ATPase isoform 2 (SERCA2).
Medpage Today on MSN
3 天
Case Strengthens for Cardiac Myosin Inhibitor in SEQUOIA-HCM
Secondary efficacy analyses of the pivotal SEQUOIA-HCM trial continued to favor aficamten, supporting a potential role for ...
News Medical on MSN
7 天
Multi-omics analysis reveals mechanism of action for ruthenium-based anti-cancer agent
This study is led by Prof. Cai-Ping Tan, Prof. Zong-Wan Mao (MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, ...
SiliconRepublic
1 天
Irish-led study bags EU funding for neurodegenerative diseases
University of Galway will lead a new research project aimed at understanding the development of neurodegenerative diseases.
Opinion
Chemistry World
7 天
Opinion
A chemist in the flower garden
So he hired himself out anonymously to a lady in another expensive neighborhood who did have garden space, telling her that ...
生物谷
12 天
多篇重要研究成果解读科学家们在人类癌症转移研究领域取得的新 ...
谈及癌症转移,一句话总结就是一个巴掌拍不响。这是纪念斯隆-凯特琳癌症中心(MSK)研究人员领导的一项新研究的主要发现之一:TGF-β和RAS信号通路共同促进了肺腺癌的扩散,而肺腺癌是全球癌症死亡的主要原因。近日,一篇发表在国际杂志 Cell 上题为 “TGF-β and RAS jointly unmask primed enhancers to drive metastasis” ...
2 天
Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with ...
Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at ...
9 天
Foghorn Therapeutics: Holding for FHD-286 Clinical Trial Outcomes and Financial Position ...
Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Foghorn Therapeutics (FHTX – Research Report) yesterday and set a price ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈